2022 Annual Meeting

Session: Engineering Protein Therapeutics

Chair

Raeeszadeh-Sarmazdeh, M., University of Nevada, Reno

Co-Chair

Spangler, J., Johns Hopkins University

Presentations

03:30 PM

(21a) Engineering a High Affinity Cross-Reactive Antibody to Bind VEGF-a and PlGF-2

03:48 PM

(21b) Engineering Pan-Reactive VEGF Antagonists for Neovascular Eye Diseases

04:06 PM

(21c) Discovery and Characterization of Intracellularly Stable hnRNPA2B1 Specific Nanobodies for Live-Cell Imaging and Targeted Protein Degradation

04:24 PM

(21d) Directed Evolution of Monoclonal Antibodies Against Tumor Associated Carbohydrate Antigens

04:42 PM

(21e) Engineering and Design of Tissue Inhibitor of Metalliproteinase-3 for Developing Protein Therapeutics

05:00 PM

(21f) Designing Hyperglycosylated Hemagglutinin Immunogens for Epitope-Focused Influenza Vaccines

05:18 PM

(21g) Simplifying Complex Antibody Engineering Using Machine Learning